HEALTHCARE

Natixis Corporate & Investment Banking supports corporations and financial sponsors operating in the healthcare sector through its dedicated industry group. We focus on three specific areas: pharmaceuticals (big and midcap pharma, biotech, pharma services, CDMO/CMO), healthcare services (clinics, hospitals, nursing homes, laboratories) and MedTech. We have a global on-the-ground presence and are one of the most active banks within the industry in Europe aiming to become the healthcare “go-to-bank” for our core clients

We support our clients through a comprehensive offering from advisory for M&A and strategic equity transactions to structuring complex financing through loans and high-yield bonds, all underpinned by in-depth sector research as well as Natixis CIB’s green & sustainable finance expertise.

Sector focus

Pharmaceuticals

  • Big and midcap pharma
  • Biotech
  • Generic and specialty drug manufacturers
  • Contract development and manufacturing organizations (CDMO)
  • OTC and OTX drug players
  • R&D services

Healthcare Services

  • Senior care
  • Private laboratories
  • Private clinics
  • Private and public hospitals
  • Nursing Homes

MedTech

  • Medical devices
  • In vitro diagnostics 
  • Digital health

Sector focus

Pharmaceuticals

  • Big and midcap pharma
  • Biotech
  • Generic and specialty drug manufacturers
  • Contract development and manufacturing organizations (CDMO)
  • OTC and OTX drug players
  • R&D services

Healthcare Services

  • Senior care
  • Private laboratories
  • Private clinics
  • Private and public hospitals
  • Nursing Homes

MedTech

  • Medical devices
  • In vitro diagnostics 
  • Digital health

News & Insights

Technologies at the service of sports health

19 May 2023

Natixis CIB: sustained commercial activity in 2022

02 Mar 2023

Ramsay Santé topped up the first Sustainability-Linked collateral trust

13 Oct 2022